30
DAFTAR PUSTAKA
Arneth, Borros M., 2009. Clinical Significance of Measuring Prostate-specific Antigen. Labmedicine; 40 (8): 487-491
AUA Commentary, 2000. Prostate-specific Antigen Best Practice Policy. Oncology; 14(2): 267.
Brawer MK, Kirby R, 1999. Prostate Specific Antigen ed. 2nd. Singapore: Health Press Limited
Chiang, Andrew S. et al, 2013. Utility of 5-Alpha-Reductase Inhibitors in
Active Surveillance for Favourable Risk Prostate Cancer. Can Urol
Assoc J; 7(11-12): 450-4533
Chiu, Peter Ka-Fung et al., 2011. Effect of Body Mass Index on Serum Prostate-Specific Antigen Levels among Patients Presenting with
Lower Urinary Tract Symptoms. Asian Pacific Journal of Cancer
Prevention; 12:1937-1940
Durmaz, Tahir et al., 2014. Is There a Relationship Between Acute Coronary
Syndrome and Prostate Specific Antigen Level?. Urology Journal; 11
(1): 1278-1286
Eknoyan, Garabed, 2008. Adolphe Quetelet (1796-1874): The Average Man and Indices of Obesity. Nephrol. Dial. Transplant; 23: 47–51
Erlangga N, Dimas, 2007. Ketepatan Diagnostik Prostat Spesifik Antigen pada
Keganasan Prostat di Rumah Sakit Dokter Kariadi Semarang.
Semarang: Fakultas Kedokteran Universitas Diponegoro
Garrow JS, Webster J., 1985. Quatelet’s Index (W/H)2 as A Measure of Fatness. Int. J. Obes. Related Metabolic Disord.; 9: 147-153
Ganesh, B. et al., 2011. Risk Factors for Prostate Cancer: An Hospital-Based
Case-Control Study from Mumbai, India. Indian J Urol.; 27(3): 345–
350
Ikatan Ahli Urologi Indonesia, 2009. Pedoman Penatalaksanaan BPH di Indonesia.
31
Ikatan Ahli Urologi Indonesia, 2011. Pedoman Penatalaksanaan Kanker Prostat.
Joseph E, Oesterling, 1991. Prostate Specific Antigen, a Crucial Assesment of
the Most Useful Tumor Markers for Adenocarcinoma of the Prostate.
The Journal Of Urology; 145: 907-923.
K. O. H, William et al., 2000. Neoplasm of the Prostate. Dalam: C. Bast, Robert et al.Holland - Frei Cancer Medicine 5th ed.. USA : BC Decker Inc
Lee, Sang Hun et al, 2013. Impact of Treatment with Statins on Prostate-Specific Antigen and Prostate Volume in Patients with Benign Prostatic Hyperplasia. Korean Journal of Urology; 54: 750-755
Lilja H. et al, 1991. Prostate-specific Antigen in Serum occurs Predominately
in Complex with Α1-anticymptrypsin. Clin. Chem., 37:1618-1625
Lionel L, Banez et al, 2007. Obesity-related Plasma Hemodilution and PSA
Concentration among Men with Prostate Cancer. The Journal of the
American Medical Association; 298: 2275–2280.
Montironi R, Mazzucchelli R, Algaba F., 2000. Prostate-specific Antigen as a Marker of Prostate Disease. Virchows Arch.; 436: 297-304.
Muller, Heiko et al, 2009. Association of Diabetes and Body Mass Index with Levels of Prostate-specific Antigen: Implications for Correction of
Prostate-specific Antigen Cutoff Values. Cancer Epidemiol Biomarkers
Prev; 18: 1350-1356
Partin, Alan W.. et al. 2012. Campbell-Walsh Urology, Tenth Edition: Prostate. Amerika: Elsevier Saunders
Soegondo, Sidartawan & Purnamasari, Dyah, 2006. Sindrom Metabolik.
Dalam: Sudoyo, Aru W. dkk., 2009. Buku Ajar Ilmu Penyakit Dalam
jilid III ed. 5. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit
Dalam Fakultas Kedikteran Universitas Indonesia
Tanagho, Emil A., McAninch, Jack W., 2008. Smith’s General Urology edisi
17: Anatomy of the Genitourinary Tract. San Francisco: The
McGraw-Hill Companies, Inc.
32
WHO, 2000. Technical Report Series 894; Obesity; Preventing and Managing
the Global Epidemic. Swiss: WHO
WHO. BMI Classification. Di akses pada: 26 Mei 2014. Dari:
